Literature DB >> 17106199

Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.

Hecheng Li1, Yawei Zhang, Hui Cai, Jiaqing Xiang.   

Abstract

BACKGROUND/AIMS: Lymph nodes in patients with squamous cell carcinoma of the thoracic esophagus might be involved with metastases at cervical, mediastinal, and abdominal sites. The range of lymph node dissection is still controversial. The pattern of lymph node metastasis and factors that are correlated with lymph node metastasis affect the surgical procedure of lymph node dissection. The purpose of the present study was to explore the pattern of lymph node metastasis and factors that are correlated with lymph node metastasis in patients with esophageal cancer who underwent three-field lymphadenectomy.
METHODS: Lymph node metastases in 230 patients who underwent radical esophagectomy with three-field lymphadenectomy were analyzed. The metastatic sites of lymph nodes were correlated with tumor location by chi-square test. Logistic regression was used to analyze clinicopathological factors related to lymph node metastasis.
RESULTS: Lymph node metastases were found in 133 of the 230 patients (57.8%). The average number of resected lymph nodes was 25.3 +/- 11.4 (range 11-71). The proportions of lymph node metastases were 41.6, 19.44, and 8.3% in neck, thoracic mediastinum, and abdominal cavity, respectively, for patients with upper thoracic esophageal carcinomas, 33.3, 34.7, and 14%, respectively, in those with middle thoracic esophageal carcinomas, and 36.4, 34.1, and 43.2%, respectively, for patients with lower thoracic esophageal carcinomas. We did not observe any significant difference in lymph node metastatic rates among upper, middle, and lower thoracic carcinomas for cervical or thoracic nodes. The difference in lymph node metastatic rates for nodes in the abdominal cavity was significant among upper, middle, and lower thoracic carcinomas. The lower thoracic esophageal cancers were more likely to metastasize to the abdominal cavity than tumors at other thoracic sites. A logistic regression model showed that depth of tumor invasion and lymphatic vessel invasion were factors influencing lymph node metastases.
CONCLUSIONS: Based on our data, cervical and mediastinal node dissection should be performed independent of the tumor location. Abdominal node dissection should be conducted more vigorously for lower thoracic esophageal cancers than for cancers at other locations. Patients with deeper tumor invasion or lymphatic vessel invasion were more likely to develop lymph node metastases.

Entities:  

Mesh:

Year:  2006        PMID: 17106199     DOI: 10.1159/000096925

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  19 in total

1.  A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.

Authors:  X Ding; J Zhang; B Li; Z Wang; W Huang; T Zhou; Y Wei; H Li
Journal:  Br J Radiol       Date:  2012-06-14       Impact factor: 3.039

2.  Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer.

Authors:  Longfei Ma; Jingpei Li; Longlong Shao; Dong Lin; Jiaqing Xiang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

3.  Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinoma.

Authors:  Dong Lin; Longfei Ma; Ting Ye; Yunjian Pan; Longlong Shao; Zuodong Song; Shujun Jiang; Haiquan Chen; Jiaqing Xiang
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

4.  Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinoma.

Authors:  Miaomiao Li; Chengrui Fu; Wei Zhang; Wei Huang; Zhongtang Wang; Tao Zhou; Haiqun Lin; Baosheng Li
Journal:  Br J Radiol       Date:  2016-02-19       Impact factor: 3.039

5.  Optimized lymph node dissection range during progression of lower thoracic esophageal squamous cell carcinoma in the latest therapeutic surgical strategy: A retrospective analysis.

Authors:  Hiroki Harada; Kei Hosoda; Hiromitsu Moriya; Hiroaki Mieno; Akira Ema; Marie Washio; Yoshimasa Kosaka; Masahiko Watanabe; Keishi Yamashita
Journal:  Oncol Lett       Date:  2018-06-27       Impact factor: 2.967

6.  An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.

Authors:  Tarik Ghadban; Magdalena Schmidt-Yang; Magdalena Smif; Faik G Uzunoglu; Daniel R Perez; Tung Y Tsui; Alexander T El Gammal; Peter J Erbes; Veacheslav Zilbermints; Ulrich Wellner; Klaus Pantel; Jakob R Izbicki; Yogesh K Vashist
Journal:  J Hum Genet       Date:  2014-10-30       Impact factor: 3.172

7.  Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer.

Authors:  Cheng-Lin Li; Fu-Li Zhang; Ya-DI Wang; Chun Han; Guo-Gui Sun; Qing Liu; Yun-Jie Cheng; Shao-Wu Jing; Cong-Rong Yang
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

Review 8.  Lymph node dissection for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

9.  The clinical significance of subcarinal lymph node dissection in the radical resection of oesophageal cancer.

Authors:  Haibo Ma; Yin Li; Zhidan Ding; Xianben Liu; Jinliang Xu; Jianjun Qin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-08

10.  Mode of lymphadenectomy and surgical outcome of upper thoracic esophageal squamous cell carcinoma.

Authors:  Hideaki Shimada; Shinn-ichi Okazumi; Tooru Shiratori; Yasunori Akutsu; Hisahiro Matsubara
Journal:  J Gastrointest Surg       Date:  2009-01-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.